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Objective. Ibuprofen and pregabalin both have independent positive effects on postoperative pain. The aim of the study is
researching effect of 800mg i.v. ibuprofen in addition to preoperative single dose pregabalin on postoperative analgesia and
morphine consumption in posterior lumbar interbody fusion surgery. Materials and Methods. 42 adult ASA I-II physical status
patients received 150mg oral pregabalin 1 hour before surgery. Patients received either 250ml saline with 800mg i.v. ibuprofen
or saline without ibuprofen 30 minutes prior to the surgery. Postoperative analgesia was obtained by morphine patient controlled
analgesia (PCA) and 1 g i.v. paracetamol every six hours. PCA morphine consumption was recorded and postoperative pain was
evaluated by Visual Analog Scale (VAS) in postoperative recovery room, at the 1st, 2nd, 4th, 8th, 12th, 24th, 36th, and 48th hours.
Results. Postoperative pain was significantly lower in ibuprofen group in recovery room, at the 1st, 2nd, 36th, and 48th hours. Total
morphine consumption was lower in ibuprofen group at the 2nd, 4th, 8th, 12th, and 48th hours. Conclusions.Multimodal analgesia
with preoperative ibuprofen added to preoperative pregabalin safely decreases postoperative pain and total morphine consumption
in patients having posterior lumbar interbody fusion surgery, without increasing incidences of bleeding or other side effects.
1. Introduction
Acute postoperative pain remains to be a major problem,
and inadequate or excessive treatment can cause side effects,
including increased risk ofmyocardial ischemia or infarction,
thromboembolic and pulmonary complications, persistent
postoperative pain incidence, alterations in immune system,
impaired rehabilitation, increased hospital stay or readmis-
sions to the hospital, impaired quality of life, and excessive
sedation due to opioid use [1]. There are developments
regarding novel analgesic medical treatments and techniques
to be employed in preoperative, intraoperative, and postop-
erative periods to better manage acute postoperative pain.
Approaches targeting preoperative period are increasing
in prevalence and are referred to as preventive analgesia.
Preventive analgesia aims to decrease postoperative pain with
ongoing analgesic effect during surgery, therefore decreasing
afferent nociceptive neurotransmission caused by surgical
stimulation [2].
Patients having lumbar spinal fusion or laminectomy
surgeries often complain about severe postoperative pain and
postoperative rehabilitation process can be effectednegatively
[3, 4]. Many methods have been tested for preventive analge-
sia in these types of surgeries. These methods include neu-
roaxial opioid administration like continuous subcutaneous
morphine [3], intrathecal morphine injection [3], epidural
morphine [4], caudal bupivacaine and tramadol administra-
tion [5], diclofenac sodium [6], and i.v. administration of
dexketoprofen and paracetamol [7].
Although pregabalin was approved as antiepileptic and
for chronic pain, because of its antinociceptive properties it is
also used for perioperative painmanagement. Clinical studies
related to perioperative pain indicate that it has effects on re-
ducing acute neuropathic pain and decreasing opioid dose
[8]. Administration of a single dose of pregabalin before
lumbar spinal surgery has been shown to reduce severity of
postoperative pain and morphine consumption [9].
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There are positive results related to preventive use of
NSAIDs before lumbar surgery [10, 11]. The propionic acid
derivative ibuprofen has analgesic and anti-inflammatory
properties through central and peripheral blockade of cox-
1 and cox-2 isoenzymes and can also have an effect through
cox- independent pathways [12–14]. Intravenous ibuprofen
has become available in 2009 and can be used for preemptive
analgesia. Studies carried out in orthopedic surgery have
shown preoperative and postoperative administration of i.v.
ibuprofen reduced postoperative pain and opioid need [15].
We did not encounter any studies related to combined use of
ibuprofen and pregabalin before lumbar spinal surgery.
We aimed to examine the effects of adding i.v. ibuprofen
to preoperative single dose pregabalin on postoperative pain
levels, morphine consumption, and side effects in surgical
situationswhere postoperative pain is severe such as posterior
interbody fusion surgery.
2. Materials and Methods
We included consecutive 42 elective lumbar stabilization
patients between 18 and 65 years of age andwithASA (Ameri-
can Society of Anesthesiologists) I-II physical status. All par-
ticipants were informed both verbally and in writing about
details of the study before it started and informed consent
was obtained from all participants. Approval from Baskent
University Clinical Studies Ethical Committee was obtained
(Chairperson Hakan O¨zkardes¸ler, Project number KA16/71).
The study was registered to the Australian New Zealand
Clinical Trial Registry (Number ACTRN12616000591459).
We followed the Consolidated Standards of Reporting Trials
(CONSORT) guidelines for reporting randomized trials and
provided a CONSORT flow diagram (Figure 1).
Patients with history of antiepileptic drug use, allergy to
drugs to be used, severe liver, renal and gastrointestinal sys-
tem illnesses, and psychiatric illnesses, patients who refused
to participate in the study, patients with long term opioid
or NSAID use, pregnant or lactating patients, patients with
diabetes or other neuropathic diseases, and patients who
refused to use patient controlled analgesia (PCA) device were
excluded.
Demographic data of the patients were recorded. Patients
were divided randomly into two groups by computer pro-
gram to have 21 patients in each group. All patients in both
groups were given 150mg pregabalin capsule (Lyrica, Pfizer,
Germany) with a little water 1 hour prior to the surgery.
Patients in Group PI (Group Pregabalin-Ibuprofen) received
800mg i.v. ibuprofen (I˙ntrafen, 800mg/8ml i.v., Gen I˙lac¸,
Turkey) 30 minutes before surgery in 250ml saline infused
over 30 minutes. Patients in Group P (Group Pregabalin)
received 250ml saline without ibuprofen. Patients were
blinded to the study group. After patients were admitted to
the operating room standard monitorization with electro-
cardiography (ECG), peripheral oxygen saturation (SpO
2
),
and noninvasive blood pressure (NIBP) was implemented.
Anesthesia induction was obtained with 0.02mg/kg i.v.
midazolam, 2microgram/kg fentanyl, 2mg/kg propofol, and
0.6mg/kg rocuronium. Following endotracheal intubation
patients were placed under prone position for operation and
surgery was performed under inhalational anesthesia with
1-2% sevoflurane in 40%/60% O
2
/N
2
O. Type of operation,
operated lumbar area, duration of the operation, intravenous
fluids given during surgery, amount of hemorrhage, and
amount of blood transfusion were recorded. Patients were
transported to the postanesthesia care unit (PACU) after
surgery following extubation.
All patients received 0.05mg/kg morphine loading dose
in PACU followed bymorphine PCA (1mg/ml, total 100mg =
100ml, bolus 1mg, 10-minute lock interval, and 4-hour limit:
30mg morphine) device. Intravenous 1 g paracetamol was
administered every six hours, first dose to be administered
upon arrival to the ward. Postoperative pain was recorded at
0, 1, 2, 4, 8, 12, 24, 36, 48 hours during resting as VAS value
(VAS 0 cm = no pain; 10 cm = most severe pain). Pain level
during ambulation at the 24th hour and patient satisfaction
at the 48th hour were also evaluated by using VAS. Presence
of side effects such as sedation, nausea, vomiting, dizziness,
and visual disturbances was evaluated at the 1st, 2nd, 4th, 8th,
12th, 24th, 36th, and 48th hours (0 = absent; 1 = present). All
of these postoperative evaluations were done by a researcher
blinded to the patients’ groups.Morphine consumption in the
PCA was recorded simultaneously with VAS assessments.
To determine number of patients for the study 80%power
and the difference of 1.5 units in VAS measurements were
used. It was calculated that it would be appropriate to take
21 individuals in each group (total of 42 individuals). The
difference of 1.5 units in VAS was determined by pilot study
and clinical experience.
For testing categorical parameters between two groups,
cross-tab analysis was used with Chi-square test, and for
normally distributed continuous variables two independent
groups’ 𝑡-test or for nonnormal variables nonparametric
two-independent sample Mann–Whitney 𝑈 test was used.
Repeated measurements were analysed by nonparametric
𝑘-related samples Friedman test with Chi-square test. All
analyses were computed by using SPSS 15.0 statistical package
program. 𝑃 < 0.05 was accepted as significant.
3. Results
Total of 42 patients, 21 patients in each group, were enrolled in
the study between March 2016 and September 2016. Figure 1
illustrates the flow of the patients through the trial. Patient
characteristics did not differ among two groups (Table 1).
There was also no statistically significant difference between
groups regarding number of operated lumbar regions, dura-
tion of surgery, hemorrhage during surgery, blood transfu-
sion, and amount of fluids given during surgery (Table 2).
VAS scores in Group PI were significantly lower at the 0th,
1st, and 2nd hours compared to the control group (𝑃 < 0.001,
𝑃 = 0.002, and 𝑃 = 0.047, resp.). Also at the 36th and 48th
hours even though VAS scores were very low they were
significantly lower in Group PI (Figure 2). VAS scores during
ambulation evaluated at the 24th hour were significantly
lower in Group PI when compared with Group P (Group
PI: VAS = 3.28; Group P: VAS = 5.09; 𝑃 = 0.05). Morphine
consumption in Group P was significantly higher at the
postoperative 2nd, 4th, 8th, 12th, and 48th hours (𝑃 = 0.002,
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Assessed for eligibility (n = 48)
Excluded (n = 6)
(i) Not meeting inclusion criteria (n = 4)
(ii) Declined to participate (n = 2)
Randomized (n = 42)
Enrollment 
Allocation
 
Allocated to control pregabalin group (n = 21)
(i) Received allocated intervention (n = 21)
(ii) Did not receive allocated intervention (n = 0)
Allocated to pregabalin and ibuprofen
preemptive treatment group (n = 21)
(i) Received allocated intervention (n = 21)
(ii) Did not receive allocated intervention (n = 0)
Lost to follow-up (n = 0) 
Discontinued intervention (n = 0) 
Follow-up
Lost to follow-up (n = 0)
Discontinued intervention (n = 0)
Analysis
Analysed (n = 21)
(i) Excluded from analysis (n = 0)  Analysed (n = 21)
(i) Excluded from analysis (n = 0)
Figure 1: CONSORT flow diagram.
Table 1: Demographic data of patients.
Group Pregabalin Group Pregabalin + Ibuprofen 𝑃 value
ASA (I/II) 6/15 7/14 𝑃 = 0.739Chi-square: 0.111
Gender (male/female) 11/10 8/13 𝑃 = 0.352Chi-square: 0.865
Age 56.4 ± 15.63 56.3 ± 10.80 𝑃 = 0.649
𝑇: 0.459
Height 170.09 ± 8.23 165.42 ± 7.20 𝑃 = 0.058
𝑇: −1.953
Body weight 83.61 ± 16.20 78.52 ± 9.64 𝑃 = 0.461
𝑍: −0.737
Body mass index 28.60 ± 3.51 28.65 ± 3.33 𝑃 = 0.957
𝑇: 0.054
Data are shown as patient number or value ± standard deviation.
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Table 2: Surgery related data.
Group Pregabalin Group Pregabalin + Ibuprofen 𝑃 value
Number of operated lumbar regions (1/2/3) 3/16/2 4/17/0 𝑃 = 0.337Chi-square: 2.173
Duration of surgery (min) 121 ± 35.7 115.6 ± 22.3 𝑃 = 0.558
𝑇: 0.590
Hemorrhage during surgery (ml) 264.2 ± 119.5 416.6 ± 275.3 𝑃 = 0.649
𝑇: 0.459
Blood transfusion (yes/no) 1/20 3/18 𝑃 = 0.293Chi-square: 1.105
Amount of fluids given during surgery (ml) 1700 ± 433.5 1823.8 ± 538.1 𝑃 = 0.085
𝑍: −1.724
Data are shown as patient number or value ± standard deviation.
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Figure 3: Total morphine consumption. ∗Statistifical significance
between two groups.
𝑃 = 0.006, 𝑃 = 0.009, 𝑃 = 0.018, and 𝑃 = 0.043, resp.)
(Figure 3). There was no statistically significant difference
between groups regarding patient satisfaction.
There was no significant difference between groups
regarding sedation, nausea, vomiting, dizziness, and visual
disturbances (Table 3).
4. Discussion
According to the results of this study preoperative single
dose i.v. ibuprofen in addition to preemptive pregabalin
significantly reduced pain levels in the first two postoperative
hours and reduced morphine consumption especially in the
first 12 hours. In a study with a total of 206 orthopedic or
abdominal surgery patients, postoperative pain levels and
morphine consumption were reported to be lower in patients
who received 800mg i.v. ibuprofen every 6 hours [15]. Again
in another study with 406 abdominal or orthopedic surgery
patients, placebo and 400mg and 800mg of ibuprofen were
compared and it has been shown that 800mg ibuprofen
reduces postoperative pain andmorphine consumptionmore
effectively [16]. Unlike our study, in both these studies
the first ibuprofen dose was given during wound closure
and drug was administered every 6 hours in postoperative
period. However, in our study, effect of addition of single
dose i.v. ibuprofen to preoperative pregabalin was examined.
Therefore, VAS scores were significantly lower in PACU, at
the 1st and 2nd hours, whereas no statistical significance was
found between groups in the 4th, 8th, and 12th hours even
though VAS values were found to be lower in Group PI.
Total morphine consumption continued to be signifi-
cantly lower during the first 12 hours. Results of this study
show preoperative use of drugs that have different mecha-
nisms of action and multimodal analgesia, reducing post-
operative pain and morphine consumption [16]. Decreased
amount of analgesic consumption in multimodal analgesia
reduces incidence of undesirable side effects and increases
patient comfort. Use of pregabalin together with NSAID as
preemptive multimodal analgesia in lumbar surgeries has
been shown to be effective in recent studies. Kim et al.
reported that a multimodal preemptive regimen of celecoxib,
pregabalin, oxycodone, and acetaminophen provides more
effective postoperative pain control compared to intravenous
morphine alone in patients having lumbar fusion surgery
[17]. Garcia et al. also reported that preemptive celecoxib
and pregabalin reduced both postoperative pain levels and
morphine consumption in a similar study [18].
Despite its popularity in the last two decades, there are
increasing concerns about studies for preventive analgesia.
Preventive analgesia is demonstrated when postoperative
pain or analgesic use reduced beyond the duration of the
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Table 3: Adverse side effects.
Group Pregabalin Group pregabalin + Ibuprofen 𝑃 value
Nausea/vomiting (yes/no) 2/19 1/20 𝑃 = 0.549Chi-square: 0.359
Sedation (yes/no) 6/15 8/13 𝑃 = 0.513Chi-square: 0.429
Visual disturbances (yes/no) 2/19 1/20 𝑃 = 0.549Chi-square: 0.359
Dizziness (yes/no) 6/15 8/13 𝑃 = 0.513Chi-square: 0.429
Data are shown as patient number.
target drug, which is defined as 5.5 half-lives of the target drug
[19]. When we examined our results, it was shown that pain
intensity reduced only in the first 2 hours after 2-hour average
surgery duration.We know that 800mg i.v. ibuprofen has 2.4-
hour elimination half-life, so we can think our analgesic effect
is a direct analgesic effect in the form ofmultimodal analgesia
with pregabalin instead of preventive analgesia [12].
Although there are reports about pregabalin reducing
postoperative pain if used preoperatively, its exact mecha-
nism of action is not clear. Even though gabapentinoids bind
to alpha2kappa subunit of presynaptic voltage gated calcium
channels, because this subunit’s upregulation after injury
takes several days, this is not thought to be the mechanism
responsible for acute postoperative analgesia [20]. There are
studies that report that this effect of gabapentinoids can be
through noradrenergic descending pathway [21]. According
to results of our study analgesic effect is increased together
with the aforementioned mechanisms of NSAID, regardless
of their mechanism of action.
In our study even though the amount of hemorrhage
appears to be higher in ibuprofen group, there was not a
statistically significant increase in hemorrhage; also there was
not an increase in the need for blood transfusion. Ibuprofen,
like otherNSAIDs, is known to inhibit thromboxane in a dose
related manner [22]. From the two drugs that are approved
to be used intravenously ketorolac is contraindicated before
surgery whereas i.v. ibuprofen is approved in adults for mild
pain and as an adjunct to opioids for moderate to severe
pain, it can be used perioperatively for surgeries other than
CABG [12]. In a study with 185 orthopedic patients first dose
of ibuprofen was given before anesthesia induction and even
though the amount of intraoperative hemorrhage was not
recorded the amount of total blood transfusions was not
increased significantly [23]. In addition, it was reported that
ibuprofen can be safely used regarding other side effects.
We also did not see any significant increase in side effects
regarding our use of single dose ibuprofen.
There are some limitations to this study. Since we wanted
to evaluate preoperative effect of ibuprofen we decided to
administer a single dose but postoperative analgesia levels
could be higher if postoperative doses were added. Future
studies should evaluate incidence of gastrointestinal and
renal complications in postoperative period as a result of
proposed treatment. In addition, the study would be more
significant if a third group with ibuprofen given at the end
of the operation was implemented and we could evaluate
whether the effect of ibuprofen is preventive or not.
5. Conclusion
In conclusion, addition of preoperative single dose of i.v.
ibuprofen to preoperative single dose of oral pregabalin in
posterior lumbar interbody fusion surgery patients provided
significant analgesic effect in early postoperative period and
also significantly reduced postoperative morphine consump-
tion without increasing incidence of side effects. Higher
quality of analgesia can be achieved with the recommended
doses of 800mg every 6 hours, but probably increase in
incidence of side effects would also be inevitable.
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